GENEVA - The World Health Organisation said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalised patients with Covid-19 after they failed to reduce mortality.
"These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalised Covid-19 patients when compared to standard of care. "Solidarity trial investigators will interrupt the trials with immediate effect," the WHO said in a statement, referring to large multi-country trials that the agency is leading.
The UN agency said that the decision, taken on the recommendation of the trial's international steering committee, does not affect other studies where the drugs are used for non-hospitalised patients or as a prophylaxis. Another arm of the WHO-led trial is looking at the potential effect of Gilead's antiviral drug remdesivir on Covid-19.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
COVID-19: WHO expects first results from drug trials within two weeksGENEVA: The World Health Organization (WHO) should soon get results from clinical trials it is conducting of drugs that might be effective in ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
COVID-19 vaccines to enter late-stage trial by end of July: FauciCOVID-19 vaccine candidates will enter late-stage clinical studies by the end of the month, with others beginning in August, September and ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Golf: Olesen's European Tour ban lifted after Covid-19 delays trialLONDON (REUTERS) - Thorbjorn Olesen's ban has been lifted by the European Tour after his trial for misconduct was postponed due to the Covid-19 pandemic, the tour's governing body said on Thursday (July 2).. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »
India approves human trials for second COVID-19 vaccine candidateZydus has received approval from Indian regulators to begin human studies for its COVID-19 vaccine contender, the drugmaker said on Friday, as the ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Indonesia reports 1,301 new Covid-19 cases, 49 deaths
Source: TODAYonline - 🏆 1. / 99 Read more »
Beijing won't require proof of Covid-19 test for some residents leaving cityBEIJING (REUTERS) - Beijing, starting on Saturday (July 4), will no longer require some residents seeking to travel out of the Chinese capital to show proof that they have tested negative for Covid-19, a municipal official said on Friday.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »